Clinical Trial Update: Platelet Reactivity After Cessation of Clopid in the Setting of Coronary Stent Implantation I: PRACTICE I

View source ↗

Summary

This completed trial update reports on platelet reactivity after stopping clopidogrel in patients with coronary artery disease and coronary stents (PRACTICE I).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Clopid (clopidogrel)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Coronary Disease | Status: COMPLETED